BioMark Diagnostics, Inc. (BUX.CX)

0.50 +0.02 (+5.26%) CAD  |  CNSX  |  Dec 08, 10:56
More

BioMark Diagnostics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for BUX.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Justera Health Ltd. Upgrade
Neural Therapeutics, Inc. --
ARCpoint, Inc. Upgrade
Biocure Technology, Inc. Upgrade
Core One Labs, Inc. --